date:Jan 23, 2014
Royal DSM, the life sciences and materials sciences company, has reported preliminary, unaudited, results for 2013 and provided an outlook for 2014. Final audited results, in conjunction with its Integrated Annual Report, will be published as scheduled on 26 February 2014.
DSM delivered roughly 20% higher EBITDA (,314 million vs. 1,109 million) for the full year 2013, in spite of what the company described as the challenging economic environment. For Q4 the company realized an approximately 30%